4//SEC Filing
Merck & Co. Inc. 4
Accession 0001225208-14-024549
$MRKCIK 0000310158operating
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 6:55 PM ET
Size
8.2 KB
Accession
0001225208-14-024549
Insider Transaction Report
Form 4
Kuhlik Bruce N
Exec. V.P. and General Counsel
Transactions
- Exercise/Conversion
Common Stock
2014-12-08$51.02/sh+50,000$2,551,000→ 178,467.496 total - Sale
Common Stock
2014-12-08$62.00/sh−50,000$3,100,000→ 128,467.496 total - Exercise/Conversion
Stock Option (right to buy)
2014-12-08−50,000→ 0 totalExercise: $51.02From: 2008-08-01Exp: 2017-07-31→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- [F2]Holdings include shares acquired in dividend reinvestment transactions.
- [F3]The option became exercisable in equal installments on 8/1/2008, 8/1/2009 and 8/1/2010.
Documents
Issuer
Merck & Co. Inc.
CIK 0000310158
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000310158
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 6:55 PM ET
- Size
- 8.2 KB